ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM_BE

Venus Remedies Limited VENUSREM_BE listed on NSE and deals in

Announcements and dividends declared by Venus Remedies Limited VENUSREM_BE

Venus Remedies gets new market authorisations for drugs in Vietnam
Pharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and Irinotecan. These approvals expand the company's presence in South Asia's growing pharmaceutical market. This marks 29 active produ
Announcement as on 09 November 2025

Venus Remedies gets GMP approval for pre-filled syringe facility
Indian pharmaceutical company Venus Remedies received a significant approval from the Malaysian authorities. The company's Baddi facility, equipped with advanced robotic technology, met the stringent quality standards for producing pre-filled syringes. Thi
Announcement as on 05 November 2024

Venus Remedies get market authorisations for two cancer drugs from Morocco, Philippines
Venus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Philippines. These approvals are part of the company's strategy to expand its oncology range and meet the growing global d
Announcement as on 30 September 2024

Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
​​ Saransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our global expansion strategy. We are looking forward to introducing the entire range of our oncology products in Uk
Announcement as on 18 March 2024

Venus Remedies secures GMP approval from UNICEF
Venus Remedies announced that it has secured good manufacturing practices (GMP) approval from the United Nations Children's Fund (UNICEF) to supply Cephalosporin antibiotics for treating infections.
Announcement as on 11 March 2024

Announcements by Venus Remedies Limited first page | Next page |

VENUSREM_BE Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 744.28
  • 12Day Average: 738.52
  • 20Day Average: 751.16
  • 50Day Average: 683.39
  • 100Day Average: 580.82
  • 150Day Average: 473.36
  • 200Day Average: 395.65

VENUSREM_BE Indicators & signals

Indicator MACD (12,26,9)

744.01, 735.27, 15.82
Indicator MACD is in positive zone

Indicator ADX (14)

1.61, 21.09, 20.43
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 62
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM_BE Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Thu Jan 2026 743.75 719.00 to 754.00 2% 0.29 times
21 Wed Jan 2026 729.15 690.00 to 740.00 0.4% 0.63 times
20 Tue Jan 2026 726.25 722.50 to 767.00 -4.5% 0.91 times
19 Mon Jan 2026 760.50 737.00 to 780.70 -0.16% 0.41 times
16 Fri Jan 2026 761.75 741.20 to 790.00 -1% 1.26 times
14 Wed Jan 2026 769.45 745.10 to 780.70 3.48% 1.5 times
13 Tue Jan 2026 743.55 702.55 to 743.55 5% 0.77 times
12 Mon Jan 2026 708.15 685.55 to 734.70 -1.86% 1.15 times
09 Fri Jan 2026 721.60 685.00 to 729.95 1.9% 0.78 times
08 Thu Jan 2026 708.15 707.10 to 742.00 -4.86% 2.08 times
07 Wed Jan 2026 744.30 730.00 to 765.40 -0.17% 0.52 times
06 Tue Jan 2026 745.60 735.00 to 769.95 -2.28% 0.73 times

Videos related to: VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top